Blood Grouping Reagent Market: By Product (Consumables, Instruments), By Technique (PCR-based and Microarray Technique, Assay-Based Techniques, Massively Parallel Sequencing Techniques, Other Techniques), By Test Type (Antibody Screening, HLA Typing, Cross-Matching Tests, ABO Blood Tests, Antigen Typing), By End-user (Hospitals, Blood Banks, Clinical Laboratories) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Blood Grouping Reagent Market size was valued at USD 2,864 billion in 2023 and is poised to grow at a CAGR of 8.9% from 2024-2030. Blood grouping reagents are solutions used to determine ABO, Rhesus, Kell, and MNS blood groups. These divisions of human blood are all depending on whether or not the red blood cells' surfaces contain particular antigens. In the test, red blood cells that carry a specific antigen clump together as a result of the reagents indicating positive results. One of the main drivers of the blood grouping market is the rising need for organ and blood transplants. According to the American Red Cross, an estimated 6.8 million people in the U.S. donate blood with almost 13.6 million units of whole blood and RBCs collected in a year further increasing the blood grouping market. The increased number of patients with platelet erectile dysfunction like thrombocytopenia, cancer, myeloproliferative disorders (MPDs), myelodysplasia, and paraproteinemia is expected to create lucrative opportunities for further development in the market owing to the imperative need for surgeons and doctors to detect the biochemical composition to form a link between disease and druggable target.

Based on the technique outlook, PCR-based and microarray techniques are dominating the market owing to the low cost, ease, and versatility in, in vitro methods for amplifying defined target RBC polymorphic regions. Moreover, the prevalence of anaemia, kidney diseases, and increased accident rates have created a large demand for the blood grouping market. According to WHO, 1.3 million people die each year, along with 20-50 million people suffering injuries, with many incurring a disability as a result of injury from road traffic crashes further increasing the demand for blood grouping reagent market. Furthermore, based on test type, antibody screening is used extensively for documenting exposure to infectious agents, assessing immune status to microorganisms determining the cause of a transfusion reaction of an organ transplant, and tracking the gradual progression of infection or autoimmune disease. The development of new infrastructure, urbanization, and the rise in government campaigns to raise public awareness of the benefits of voluntary blood and organ donations have led to the burgeon of the blood-g grouping reagent market. Furthermore, the rising prevalence of chronic diseases and the accelerating demand for early detection by blood grouping is leading to market growth.

Blood Grouping Reagents Market Key Developments:

  • In July 2021, PerkinElmer acquired BioLegend, a leading developer of antibodies and other research tools, by signing a $5.25 Billion deal becoming a significant supplier of reagents and supplies for the development of diagnostic tests and precision medicine.
  • In October 2020, Alba Bioscience Limited received approval from FDA for ALBAclone Anti-C (Human/Murine Monoclonal), ALBAclone, Anti-e, (Human/Murine Monoclonal), and ALBAclone Anti-Cw (Human/Murine Monoclonal).

Global Blood Grouping Reagents Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

8.9%

Largest Market

Europe

Fastest Growing Market

North America
Blood Grouping Reagent Market Dynamics

Factors such as rising in the prevalence rate of various diseases, dire need for the blood during surgical procedures, rise in the government initiatives about necessity of the donation of blood, safe blood transfusion, campaigns on blood donation are propelling the growth of blood grouping reagents market. However, lacking in the awareness, lack of trained and skilled professionals which may lead to risks in transfusion hence, diminishing the growth of blood bank reagents globally.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Global Blood Grouping Reagents Market Segmentation

By Product
  • Consumables
  • Instruments
By Technique
  • PCR-based and Microarray Technique
  • Assay-Based Techniques
  • Massively Parallel Sequencing Techniques
  • Other Techniques
By Test Type
  • Antibody Screening
  • HLA Typing
  • Cross-Matching Tests
  • ABO Blood Tests
  • Antigen Typing
By End-user
  • Hospitals
  • Blood Banks
  • Clinical Laboratories

Frequently Asked Questions

The blood grouping reagents market size was valued at USD 2,864 billion in 2023

The blood grouping reagents market key players are: Grifols, S.A. (Spain) and Bio-Rad Laboratories, Inc. (U.S.) Immucor, Inc. (U.S.) Quotient, Ltd. (U.S.) Novacyt Group (France) Ortho Clinical Diagnostics, Inc. (U.S.) BAG Healthcare GmbH (Germany) Day medical SA (Switzerland) Rapid Labs (U.K.) AXO Science (France) DIAGAST (France)

The blood grouping reagents market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

1. Executive Summary
2. Global Blood Grouping Reagents Market Introduction
2.1. Global Blood Grouping Reagents Market Taxonomy
2.2. Global Blood Grouping Reagents  Market Definitions
2.2.1. Product
2.2.2. Technique
2.2.3. Test Type
2.2.4. End-User
3. Global Blood Grouping Reagents Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Blood Grouping Reagents  Market Dynamic Factors - Impact Analysis
3.6. Global Blood Grouping Reagents  Market  Regulations
3.6.1. U.S.
3.6.2. Europe
3.7. Global Blood Grouping Reagents  Market Trends
4. Global Blood Grouping Reagents Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
4.1. Market Analysis, 2012  2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. Global Blood Grouping Reagents Market, By Product, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1. Consumables
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Instruments
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Global Blood Grouping Reagents Market Forecast, By Technique, 2019 - 2023 and Forecast, 2024 - 2030
6.1. PCR-based and Microarray Technique
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Assay-Based Techniques
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Massively Parallel Sequencing Techniques
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Other Techniques
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Blood Grouping Reagents Market Forecast, By Test Type, 2019 - 2023 and Forecast, 2024 - 2030
7.1. Antibody Screening
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. HLA Typing
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Cross-Matching Tests
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. ABO Blood Tests
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Antigen Typing
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. Global Blood Grouping Reagents Market Forecast, By End-Use, 2019 - 2023 and Forecast, 2024 - 2030
8.1. Hospitals
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Blood Banks
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Clinical Laboratories
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Blood Grouping Reagents Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Blood Grouping Reagents  Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Region, 2024 - 2030
10. North America Blood Grouping Reagents Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
10.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Consumables
10.1.2. Instruments
10.2. Technique Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. PCR-based and Microarray Technique
10.2.2. Assay-Based Techniques
10.2.3. Massively Parallel Sequencing Techniques
10.2.4. Other Techniques
10.3. Test Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Antibody Screening
10.3.2. HLA Typing
10.3.3. Cross-Matching Tests
10.3.4. ABO Blood Tests
10.3.5. Antigen Typing
10.4. End -Use Analysis, 2012- 2019 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.4.1. Hospitals
10.4.2. Blood Banks
10.4.3. Clinical Laboratories
10.5. Country Analysis 2019 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. U.S.
10.5.2. Canada
10.6. North America Blood Grouping Reagents  Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Country, 2018 
10.7. North America Blood Grouping Reagents  Market Dynamics  Trends
11. Europe Blood Grouping Reagents Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
11.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Consumables
11.1.2. Instruments
11.2. Technique Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. PCR-based and Microarray Technique
11.2.2. Assay-Based Techniques
11.2.3. Massively Parallel Sequencing Techniques
11.2.4. Other Techniques
11.3. Test Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Antibody Screening
11.3.2. HLA Typing
11.3.3. Cross-Matching Tests
11.3.4. ABO Blood Tests
11.3.5. Antigen Typing
11.4. End -Use Analysis, 2012- 2019 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.4.1. Hospitals
11.4.2. Blood Banks
11.4.3. Clinical Laboratories
11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Rest of Europe
11.6. Europe Blood Grouping Reagents  Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Country, 2024 - 2030
11.7. Europe Blood Grouping Reagents  Market Dynamics Trends
12. Asia-Pacific Blood Grouping Reagents Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
12.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Consumables
12.1.2. Instruments
12.2. Technique Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. PCR-based and Microarray Technique
12.2.2. Assay-Based Techniques
12.2.3. Massively Parallel Sequencing Techniques
12.2.4. Other Techniques
12.3. Test Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Antibody Screening
12.3.2. HLA Typing
12.3.3. Cross-Matching Tests
12.3.4. ABO Blood Tests
12.3.5. Antigen Typing
12.4. End -Use Analysis, 2012- 2019 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.4.1. Hospitals
12.4.2. Blood Banks
12.4.3. Clinical Laboratories
12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Blood Grouping Reagents  Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Country, 2024 - 2030
12.7. Asia-Pacific Blood Grouping Reagents  Market Dynamics €“ Trends
13. Latin America Blood Grouping Reagents Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
13.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Consumables
13.1.2. Instruments
13.2. Technique Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. PCR-based and Microarray Technique
13.2.2. Assay-Based Techniques
13.2.3. Massively Parallel Sequencing Techniques
13.2.4. Other Techniques
13.3. Test Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Antibody Screening
13.3.2. HLA Typing
13.3.3. Cross-Matching Tests
13.3.4. ABO Blood Tests
13.3.5. Antigen Typing
13.4. End -Use Analysis, 2018- 2022 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.4.1. Hospitals
13.4.2. Blood Banks
13.4.3. Clinical Laboratories
13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico 13.5.3. Argentina
13.5.4. Venezuela
13.5.5. Rest of Latin America
13.6. Latin America Blood Grouping Reagents Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Country, 2024 - 2030
13.7. Latin America Blood Grouping Reagents  Market Dynamics Trends
14. Middle East and Africa Blood Grouping Reagents Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
14.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Consumables
14.1.2. Instruments
14.2. Technique Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. PCR-based and Microarray Technique
14.2.2. Assay-Based Techniques
14.2.3. Massively Parallel Sequencing Techniques
14.2.4. Other Techniques
14.3. Test Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.3.1. Antibody Screening
14.3.2. HLA Typing
14.3.3. Cross-Matching Tests
14.3.4. ABO Blood Tests
14.3.5. Antigen Typing
14.4. End -Use Analysis, 2018- 2022 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.4.1. Hospitals
14.4.2. Blood Banks
14.4.3. Clinical Laboratories
14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Blood Grouping Reagents Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Country, 2024 - 2030
14.7. MEA Blood Grouping Reagents Market Dynamics Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Grifols, S.A. (Spain)
15.2.2. Bio-Rad Laboratories, Inc. (U.S.)
15.2.3. Immucor, Inc. (U.S.)
15.2.4. Quotient, Ltd. (U.S.)
15.2.5. Novacyt Group (France)
15.2.6. Ortho Clinical Diagnostics, Inc. (U.S.)
15.2.7. BAG Healthcare GmbH (Germany)
15.2.8. Day medical SA (Switzerland)
15.2.9. Rapid Labs (U.K.)
15.2.10. AXO Science (France)
15.2.11. DIAGAST (France)
16. Research Methodology
17. Key Assumptions and Acronyms
  • Grifols, S.A. (Spain)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Immucor, Inc. (U.S.)
  • Quotient, Ltd. (U.S.)
  • Novacyt Group (France)
  • Ortho Clinical Diagnostics, Inc. (U.S.)
  • BAG Healthcare GmbH (Germany)
  • Day medical SA (Switzerland)
  • Rapid Labs (U.K.)
  • AXO Science (France)
  • DIAGAST (France)

Adjacent Markets